Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB

NFkB activity is critical for survival and proliferation of normal lymphoid cells and many kinds of B-cell tumors, including multiple myeloma (MM). NFkB activating mutations, which are apparent progression events, enable MM tumors to become less dependent on bone marrow signals that activate NFkB. M...

Full description

Saved in:
Bibliographic Details
Main Authors: Demchenko, Yulia N., Brents, Leslie A., Li, Zhihong, Bergsagel, Leif P., McGee, Lawrence R., Kuehl, Michael W.
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2014
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4147345/
https://ncbi.nlm.nih.gov/pubmed/24980832
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items